Falciparum Completed Phase 4 Trials for Atovaquone (DB01117)

IndicationStatusPhase
DBCOND0031678 (Falciparum)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00444106Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory FunctionTreatment